Sustained expression of negative regulators of myelination protects schwann cells from dysmyelination in a Charcot–Marie–Tooth 1B mouse model

F Florio, C Ferri, C Scapin, ML Feltri, L Wrabetz, M D’Antonio

Research output: Contribution to journalArticle

Abstract

Schwann cell differentiation and myelination in the PNS are the result of fine-tuning of positive and negative transcriptional regulators. As myelination starts, negative regulators are downregulated, whereas positive ones are upregulated. Fully differentiated Schwann cells maintain an extraordinary plasticity and can transdifferentiate into “repair” Schwann cells after nerve injury. Reactivation of negative regulators of myelination is essential to generate repair Schwann cells. Negative regulators have also been implicated in demyelinating neuropathies, although their role in disease remains elusive. Here, we used a mouse model of Charcot–Marie–Tooth neuropathy type 1B (CMT1B), the P0S63del mouse characterized by ER stress and the activation of the unfolded protein response, to show that adult Schwann cells are in a partial differentiation state because they overexpress transcription factors that are normally expressed only before myelination. We provide evidence that two of these factors, Sox2 and Id2, act as negative regulators of myelination in vivo. However, their sustained expression in neuropathy is protective because ablation of Sox2 or/and Id2 from S63del mice of both sexes results in worsening of the dysmyelinating phenotype. This is accompanied by increased levels of mutant P0 expression and exacerbation of ER stress, suggesting that limited differentiation may represent a novel adaptive mechanism through which Schwann cells counter the toxic effect of a mutant terminal differentiation protein. © 2018 the authors.
Original languageEnglish
Pages (from-to)4275-4287
Number of pages13
JournalJournal of Neuroscience
Volume38
Issue number18
DOIs
Publication statusPublished - 2018

    Fingerprint

Cite this